OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+19.78%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.29%
AUM
$251M
AUM Growth
+$251M
(+17%)
Cap. Flow
+$11.2M
Cap. Flow
% of AUM
4.47%
Top 10 Holdings %
Top 10 Hldgs %
49.32%
Holding
52
New
15
Increased
11
Reduced
9
Closed
6
Top Buys
1 |
AFMD
Affimed
AFMD
|
$7.95M |
2 |
Harrow
HROW
|
$4.21M |
3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$4.04M |
4 |
Axogen
AXGN
|
$3.56M |
5 |
FibroGen
FGEN
|
$3.14M |
Top Sells
1 |
Agios Pharmaceuticals
AGIO
|
$8.49M |
2 |
CMRX
Chimerix, Inc.
CMRX
|
$5.78M |
3 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$5.22M |
4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$4.39M |
5 |
KITE
Kite Pharma, Inc.
KITE
|
$4.38M |
Sector Composition
1 | Healthcare | 82.89% |